Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 101 - 125 of 475
Concurrent DeepSight™ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline)
MolecularConcurrent DeepSight™ Comprehensive 523 genes Liquid Biopsy (Somatic) + Neovare Portfolio testing (Germline) Methodology Molecular Test Description Disease Solid tumors; Breast cancer, Ovarian cancer,
Concurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue
MolecularConcurrent DeepSight™ on Liquid + siPortfolio Multi-Omics™ on Tissue Methodology Molecular Test Description Disease Solid tumorsOn Tissue: siPortfolio Multi-Omics™ • NGS (500+ genes, TMB, MSI)
LymphoSight™
LymphoSight™ Test Description Probes/Genes IHC/CISH ALK1, BCL-1, BCL-2, BCL-6, BRAF, Bob1, CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD15, CD20, CD21, CD23, CD25*, CD30, CD43, CD79a, CD138, C-MYC, EBV-LMP, Granzyme B, ICOS*, IgA, IgG, IgG4, IgM, Kappa, Ki-67, Lambda, LEF1*, Mum1, OCT2, Pax5, Perforin, PD-1, TIA1. *: Pending CISH: EBER, Kappa,
AXL Fusion
MolecularAXL Fusion Methodology Molecular Test Description Genes AXL Disease Colon adenocarcinoma, lung adenocarcinoma, cutaneous melanoma, endometrial endometrioid adenocarcinoma, and breast invasive ductal carcinoma,
BCL2 Fusion
MolecularBCL2 Fusion Methodology Molecular Test Description Genes BCL2 Disease Follicular Lymphoma and High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit.Next generation sequencing of gene panel. This gene encodes
BCOR single gene test
MolecularBCOR single gene test Methodology Molecular Test Description Genes BCOR Disease Soft tissue sarcoma, Ewing's Sarcoma, epithelial tumors, neural tumors, hematological tumors, Acute myeloid leukemia (AML),
BCR-ABL (p190, p210, p230)
MolecularBCR-ABL (p190, p210, p230) Alternative Name Philadelphia chromosome, BCR-ABL1 Major, BCR-ABL1 Minor, BCR/ABL1 Standard, BCR-ABL1 p230 Translocation, BCR/ABL1 Non-Standard Methodology Molecular Test Description
BCR/ABL Major (p210) breakpoints
MolecularBCR/ABL Major (p210) breakpoints Alternative Name Philadelphia chromosome, BCR-ABL1 Major Methodology Molecular Test Description Genes BCR/ABL1 (t(9;22) Major (p210) breakpoints Disease Chronic myeloid
BCR/ABL Major reflex to ABL Kinase Mutation
MolecularBCR/ABL Major reflex to ABL Kinase Mutation Alternative Name BCR/ABL p210 (major) reflex to ABL Kinase Muation Methodology Molecular Test Description Genes BCR/ABL1 (t(9;22) Major (p210) breakpoints &
BCR/ABL Major reflex to Minor
MolecularBCR/ABL Major reflex to Minor Alternative Name BCR/ABL p210 (major) reflex to BCR/ABL p190 (minor) Methodology Molecular Test Description Genes BCR/ABL1 (t(9;22) Major (p210) breakpoints & Minor (p190)
BCR/ABL Minor (p190) breakpoints
MolecularBCR/ABL Minor (p190) breakpoints Alternative Name BCR/ABL p190 (minor) Methodology Molecular Test Description Genes BCR/ABL1 (t(9;22)) Minor (p190) breakpoints Disease B-cell lymphoblastic leukemia/lymphoma
BIRC3 single gene test
MolecularBIRC3 single gene test Methodology Molecular Test Description Genes BIRC3 (exons 6-8) Disease Chronic lymphocytic leukemia/small lymphocytic lymphoma, splenic marginal zone lymphoma, mantle cell lymphoma,
BRAF V600 Heme Mutation Analysis
MolecularBRAF V600 Heme Mutation Analysis Methodology Molecular Test Description Genes BRAF, V600 variant(s) Disease Hairy Cell Leukemia, melanoma, thyroid cancer, lung cancer, NHL, langerhans cell histiocytosis
BRAF Mutation Analysis
MolecularBRAF Mutation Analysis Methodology Molecular Test Description Genes BRAF,V600 variant(s) Disease Hairy Cell Leukemia, melanoma, thyroid cancer, lung cancer, NHL, langerhans cell histiocytosis (LCH)Next
Germline BRCA1/BRCA2
MolecularGermline BRCA1/BRCA2 Methodology Molecular Test Description Genes BRCA 1/2 Disease Personal or family history of breast, ovarian, fallopian tube, or peritoneal cancer or whose ancestry is associated with
BTK single gene test
MolecularBTK single gene test Methodology Molecular Test Description Genes BTK (exons14-16) Disease Endometrial cancer, intestinal cancer, and skin cancer, lung adenocarcinoma, cutaneous melanoma, colon adenocarcinoma,
CALR Mutation NGS Analysis
MolecularCALR Mutation NGS Analysis Methodology Molecular Test Description Genes CALR Disease Essential Thrombocythemia and Primary MyelofibrosisNext generation sequencing of gene panel. Calreticulin is a highly
CALR Mutation PCR Analysis
MolecularCALR Mutation PCR Analysis Methodology Molecular Test Description Genes CALR Disease Essential Thrombocythemia and Primary MyelofibrosisThe calreticulin gene, called CALR , is responsible for making a
CARD11 single gene test
MolecularCARD11 single gene test Methodology Molecular Test Description Genes CARD11 (exons 2-8) Disease B cell lymphoproleferative disorders, B cell expansion, primary immunodeficiency, intestinal cancer, skin
CBL Mutation Analysis
MolecularCBL Mutation Analysis Methodology Molecular Test Description Genes CBL Disease Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia and Noonan syndrome-like disorderNext generation sequencing of gene
CCND1 Single Gene
MolecularCCND1 Single Gene Methodology Molecular Test Description Genes CCND1 Disease Endometrial cancer, breast cancer, intestinal cancer, stomach cancer, esophageal carcinomas, Von Hippel-Lindau Syndrome, mantle
CCND1/IGH (t(11;14))
MolecularCCND1/IGH (t(11;14)) Alternative Name CCND1(BCL1)/IgH t(11;14) Methodology Molecular Test Description Genes CCND1/IGH (t(11;14)) Disease Mantle cell lymphoma, multiple myeloma, follicular lymphoma, mature
CD79B single gene test
MolecularCD79B single gene test Methodology Molecular Test Description Genes CD79B (exons 4-5) Disease Hematopoietic and lymphoid cancers, intestinal cancer, and lung cancer, breast invasive ductal carcinoma, diffuse
CDK6 Mutation Analysis
MolecularCDK6 Mutation Analysis Methodology Molecular Test Description Genes CDK6 Disease Lung adenocarcinoma, breast invasive ductal carcinoma, esophageal adenocarcinoma, pancreatic adenocarcinoma, and colon adenocarcinoma,
CDK4 Mutation Analysis
MolecularCDK4 Mutation Analysis Methodology Molecular Test Description Genes CDK4 Disease Diseases associated with CDK4 include Melanoma, liposarcoma, osteosarcoma, endometrial cancer, and intestinal cancer.NGS-DNA
CEBPA Heme Mutation Analysis
MolecularCEBPA Heme Mutation Analysis Methodology Molecular Test Description Genes CEBPA Disease Familial acute myeloid leukemia with mutated CEBPA, cytogenetically normal acute myeloid leukemiaNext generation
Brain Cancer 50 Genes NGS Panel
MolecularBrain Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR, ERBB2,
Breast Cancer 50 Genes NGS Panel
MolecularBreast Cancer 50 Genes NGS Panel Methodology Molecular Test Description Genes DNA HOTSPOT GENES (44) AKT1, AKT2, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2 CTNNB1, EGFR,
